以5,6-二甲氧基-2-(4-吡啶基)-亚甲基-1-茚酮(Ⅱ)和溴化苄(Ⅲ)为原料,合成盐酸多奈哌齐的关键中间体1-苄基-4-(5,6-二甲氧基-1-茚酮-2-亚甲基)-吡啶(Ⅰ).研究了主要因素对反应的影响,n(Ⅱ)∶n(Ⅲ)=1∶1.3,反应时间60 m in,收率为92.8%....以5,6-二甲氧基-2-(4-吡啶基)-亚甲基-1-茚酮(Ⅱ)和溴化苄(Ⅲ)为原料,合成盐酸多奈哌齐的关键中间体1-苄基-4-(5,6-二甲氧基-1-茚酮-2-亚甲基)-吡啶(Ⅰ).研究了主要因素对反应的影响,n(Ⅱ)∶n(Ⅲ)=1∶1.3,反应时间60 m in,收率为92.8%.经核磁共振谱图分析确认为目标产物.进一步讨论了反应的动力学过程,并建立了动力学方程.展开更多
In order to obtain the key intermediate of vandetanib,4-chloro-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline was synthesized from methyl 4-[1-(tert-butoxycarbonyl) piperidin-4-ylmethoxy]-3-methoxybenzoate by ...In order to obtain the key intermediate of vandetanib,4-chloro-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline was synthesized from methyl 4-[1-(tert-butoxycarbonyl) piperidin-4-ylmethoxy]-3-methoxybenzoate by deprotection,methylation,nitration,reduction,ring formation and substitution reaction in an overall yield of 58%.The structures of the compound and its intermediates were determined by 1H NMR and MS.展开更多
(±)-1-Methyl-7-oxabicyclo[2.2.1]heptan-2-one (1) is a versatile chiral building block for terpenoids. It could be applied in total synthesis of eudesmanes, agarofurans and norcarotenoids. Compound (±)-1 was ...(±)-1-Methyl-7-oxabicyclo[2.2.1]heptan-2-one (1) is a versatile chiral building block for terpenoids. It could be applied in total synthesis of eudesmanes, agarofurans and norcarotenoids. Compound (±)-1 was reduced to alcohol (±)-2. Compound (±)-2 was esterified with commercial available optically pure (S)-(+)-mandelic acid. The diastereomeric ester mixture was separated with preparative HPLC method. After oxidation of the saponified products of diastereomeric ester (+)-4 and (+)-5 respectively, both optically pure enantiomers of compound 1 were prepared for the first time in four steps with an overall yield of 70%. The absolute configurations of (+)-1 and (-)-1 were determined as (+)-(1R,4S)-1-methyl-7-oxabicyclo[2.2.1] heptan-2-one and (-)-(1S,4R)-1-methyl-7-oxabicyclo[2.2.1] heptan-2-one.展开更多
文摘以5,6-二甲氧基-2-(4-吡啶基)-亚甲基-1-茚酮(Ⅱ)和溴化苄(Ⅲ)为原料,合成盐酸多奈哌齐的关键中间体1-苄基-4-(5,6-二甲氧基-1-茚酮-2-亚甲基)-吡啶(Ⅰ).研究了主要因素对反应的影响,n(Ⅱ)∶n(Ⅲ)=1∶1.3,反应时间60 m in,收率为92.8%.经核磁共振谱图分析确认为目标产物.进一步讨论了反应的动力学过程,并建立了动力学方程.
文摘In order to obtain the key intermediate of vandetanib,4-chloro-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline was synthesized from methyl 4-[1-(tert-butoxycarbonyl) piperidin-4-ylmethoxy]-3-methoxybenzoate by deprotection,methylation,nitration,reduction,ring formation and substitution reaction in an overall yield of 58%.The structures of the compound and its intermediates were determined by 1H NMR and MS.
文摘(±)-1-Methyl-7-oxabicyclo[2.2.1]heptan-2-one (1) is a versatile chiral building block for terpenoids. It could be applied in total synthesis of eudesmanes, agarofurans and norcarotenoids. Compound (±)-1 was reduced to alcohol (±)-2. Compound (±)-2 was esterified with commercial available optically pure (S)-(+)-mandelic acid. The diastereomeric ester mixture was separated with preparative HPLC method. After oxidation of the saponified products of diastereomeric ester (+)-4 and (+)-5 respectively, both optically pure enantiomers of compound 1 were prepared for the first time in four steps with an overall yield of 70%. The absolute configurations of (+)-1 and (-)-1 were determined as (+)-(1R,4S)-1-methyl-7-oxabicyclo[2.2.1] heptan-2-one and (-)-(1S,4R)-1-methyl-7-oxabicyclo[2.2.1] heptan-2-one.
